{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:00:24Z","timestamp":1785135624187,"version":"3.55.0"},"reference-count":276,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.pnpbp.2026.111846","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:59:23Z","timestamp":1784303963000},"page":"111846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Silent action of dopamine receptor antagonist in synaptic remodelling: Molecular basis of tardive dyskinesia due to chronic antipsychotic exposure"],"prefix":"10.1016","volume":"148","author":[{"given":"Wrila","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achal","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishor Kumar","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2026.111846_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107061","article-title":"Developments in pharmacogenetics, pharmacogenomics, and personalized medicine","volume":"200","author":"Abad-Santos","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coph.2007.12.002","article-title":"Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders","volume":"8","author":"Abel","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0015","article-title":"A neuroimmune framework for understanding adolescent stress and risk of alcohol misuse","volume":"54","author":"Aeschlimann","year":"2026","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.euroneuro.2024.04.012","article-title":"Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: a narrative review and recommendation for clinical practice","volume":"84","author":"Agid","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1478964","article-title":"Pharmacogenomics for neurodegenerative disorders - a focused review","volume":"15","author":"Ahmad","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.650","article-title":"Propagation of age-related diseases due to the changes of lipid peroxide and antioxidant levels in elderly people: a narrative review","volume":"5","author":"Ali","year":"2022","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0035","article-title":"Neuroinflammation and glial cell activation in mental disorders","volume":"2","author":"Almeida","year":"2019","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0040","article-title":"AI-powered precision medicine: utilizing genetic risk factor optimization to revolutionize healthcare","volume":"7","author":"Alsaedi","year":"2025","journal-title":"NAR Genom. Bioinform."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0091-3057(99)00118-5","article-title":"Coenzyme Q10 does not prevent oral dyskinesias induced by long-term haloperidol treatment of rats","volume":"64","author":"Andreassen","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0050","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.conb.2011.12.006","article-title":"Regulation of AMPA receptor trafficking and synaptic plasticity","volume":"22","author":"Anggono","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2025.1673195","article-title":"The NERD model: reflex circuit dysfunction as a systems-level driver of persistent post-concussion symptoms","volume":"19","author":"Antonucci","year":"2026","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41537-026-00747-w","article-title":"Dose reduction and discontinuation of antipsychotics in psychotic disorders: a systematic review of qualitative studies and meta-synthesis","volume":"12","author":"Aprile","year":"2026","journal-title":"Schizophrenia"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0065","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/schbul\/sbn114","article-title":"Pharmacogenetics in psychiatry: are we ready for widespread clinical use?","volume":"34","author":"Arranz","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0070","first-page":"1","article-title":"Dopaminergic modulation of synaptic plasticity, its role in neuropsychiatric disorders, and its computational modeling","volume":"10","author":"Asl","year":"2019","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2017.00108","article-title":"Neuromodulatory systems and their interactions: a review of models, theories, and experiments","author":"Avery","year":"2017","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/biology12101360","article-title":"Dopaminergic input regulates the sensitivity of indirect pathway striatal spiny neurons to brain-derived neurotrophic factor","volume":"12","author":"Ayon-Olivas","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0085","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.neuron.2018.01.006","article-title":"Dopamine\u2019s effects on corticostriatal synapses during reward-based behaviors","volume":"97","author":"Bamford","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0090","doi-asserted-by":"crossref","DOI":"10.1155\/np\/3455379","article-title":"Metabotropic glutamate receptor\u2013dependent synaptic plasticity in age-related neurodegenerative disorders","volume":"2026","author":"Basha","year":"2026","journal-title":"Neural Plast."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0095","first-page":"23","article-title":"Reactive oxygen species: physiological and physiopathological effects on synaptic plasticity","volume":"10","author":"Beckhauser","year":"2016","journal-title":"J. Exp. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40272-025-00730-5","article-title":"Neurological adverse effects of antipsychotic medication in children and young people","volume":"28","author":"Besag","year":"2026","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0105","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1136\/jnnp.52.11.1248","article-title":"Striatal dopamine D2 receptors in tardive dyskinesia: PET study","volume":"52","author":"Blin","year":"1989","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0110","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s13205-025-04468-2","article-title":"Implicating neuroinflammation in hippocampus, prefrontal cortex and amygdala with cognitive deficit: a narrative review","volume":"15","author":"Blossom","year":"2025","journal-title":"3 Biotech"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0115","doi-asserted-by":"crossref","DOI":"10.36922\/gpd.1966","article-title":"Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequences","volume":"3","author":"Blum","year":"2024","journal-title":"Gene Protein Disease"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/JCP.0b013e31828bf059","article-title":"The incidence of Tardive Dyskinesia in the study of pharmacotherapy for psychotic depression","volume":"33","author":"Blumberger","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2024.1339324","article-title":"Motor network dynamic resting state fMRI connectivity of neurotypical children in regions affected by cerebral palsy","volume":"18","author":"Boerwinkle","year":"2024","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0130","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41380-025-03229-0","article-title":"Interrelations between dopaminergic-, gabaergic- and glutamatergic neurotransmitters in antipsychotic-na\u00efve psychosis patients and the association to initial treatment response","volume":"31","author":"Bojesen","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4161\/epi.7.1.18688","article-title":"Current status and future prospects for epigenetic psychopharmacology","volume":"7","author":"Boks","year":"2012","journal-title":"Epigenetics"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.expneurol.2016.09.009","article-title":"Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia","volume":"286","author":"Bordia","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0145","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1038\/npp.2014.129","article-title":"Control of the nigrostriatal dopamine neuron activity and motor function by the tail of the ventral tegmental area","volume":"39","author":"Bourdy","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-642-25761-2_3","article-title":"Dopamine receptor signaling and current and future antipsychotic drugs","volume":"212","author":"Boyd","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098417","article-title":"Altered synaptic plasticity in Tourette\u2019s syndrome and its relationship to motor skill learning","volume":"9","author":"Brandt","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0160","first-page":"47","article-title":"The role of dopamine in Schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue","volume":"5","author":"Brisch","year":"2014","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0165","first-page":"397","article-title":"Abnormal striatal dopamine transmission in Schizophrenia","volume":"20","author":"Brunelin","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0170","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/02698811241309620","article-title":"Haloperidol dopamine receptor occupancy and antagonism correspond to delirium agitation scores and EPS risk: A PBPK-PD modeling analysis","volume":"39","author":"Burkat","year":"2025","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tins.2007.03.001","article-title":"Dopamine-mediated regulation of corticostriatal synaptic plasticity","volume":"30","author":"Calabresi","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0180","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212553","article-title":"The therapeutic role of minocycline in Parkinson\u2019s disease","volume":"8","author":"Cankaya","year":"2019","journal-title":"Drugs Context"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0185","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2147\/NDT.S196541","article-title":"Overcoming barriers to effective management of tardive dyskinesia","volume":"15","author":"Caroff","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0190","doi-asserted-by":"crossref","first-page":"493","DOI":"10.9758\/cpn.2020.18.4.493","article-title":"Recent advances in the pharmacology of Tardive Dyskinesia","volume":"18","author":"Caroff","year":"2020","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115028","article-title":"\u201cSelective\u201d serotonin 5-HT2A receptor antagonists","volume":"200","author":"Casey","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1670650","article-title":"Neuroinflammation: targeting microglia for neuroprotection and repair after spinal cord injury","volume":"16","author":"Cavalcanti","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0205","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/mds.26282","article-title":"Balancing the basal ganglia circuitry: a possible new role for Dopamine D2 receptors in health and disease","volume":"30","author":"Cazorla","year":"2015","journal-title":"Mov. Disord."},{"issue":"Apr","key":"10.1016\/j.pnpbp.2026.111846_bb0210","first-page":"74733","article-title":"Maladaptive plasticity in levodopa-induced dyskinesias and tardive dyskinesias: old and new insights on the effects of dopamine receptor pharmacology","volume":"5","author":"Cerasa","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0215","article-title":"Dopaminergic D2 receptor modulation of striatal cholinergic interneurons contributes to sequence learning","author":"Chancey","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70855","article-title":"Advanced imaging techniques (PET, fMRI, DTI) in early detection of neurodegenerative diseases: a systematic review","volume":"8","author":"Chandrasekar","year":"2025","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0225","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1196\/annals.1427.027","article-title":"Mitochondrial approaches for neuroprotection","volume":"1147","author":"Chaturvedi","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2026.101291","article-title":"Mechanistic insights and therapeutic interventions of mitochondrial quality control in chemotherapy-related cognitive impairment","volume":"74","author":"Chen","year":"2026","journal-title":"Neoplasia"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0235","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0091-3057(87)90509-0","article-title":"D1 and D2 dopamine binding site up-regulation and apomorphine-induced stereotypy","volume":"28","author":"Chipkin","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0240","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3390\/antiox14060696","article-title":"Oxidative stress: pathological driver in chronic neurodegenerative diseases","volume":"14","author":"Chong","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0245","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000477313","article-title":"Antipsychotic-induced dopamine supersensitivity psychosis: pharmacology, criteria, and therapy","volume":"86","author":"Chouinard","year":"2017","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0250","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12964-024-01572-3","article-title":"Inhibition of adenylyl cyclase by GTPase-deficient G\u03b1i is mechanistically different from that mediated by receptor-activated G\u03b1i","volume":"22","author":"Chung","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0255","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.2147\/NDT.S328301","article-title":"Tardive dyskinesia in older persons taking antipsychotics","volume":"17","author":"Citrome","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0260","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.3390\/biomedicines11092488","article-title":"Mitochondria and brain disease: a comprehensive review of pathological mechanisms and therapeutic opportunities","volume":"11","author":"Clemente-Su\u00e1rez","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0265","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/biomedicines12030494","article-title":"The implications of Cytochrome P450 2D6\/CYP2D6 polymorphism in the therapeutic response of atypical antipsychotics in adolescents with psychosis \u2014 a prospective study","volume":"12","author":"Cojocaru","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0270","first-page":"162","article-title":"Medication-induced tardive dyskinesia: a review and update","volume":"17","author":"Cornett","year":"2017","journal-title":"Ochsner J."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0275","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s40263-025-01206-3","article-title":"Strategies for switching between oral postsynaptic antidopaminergic antipsychotics in patients with Schizophrenia: a systematic review","volume":"39","author":"Correll","year":"2025","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0280","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainresbull.2011.07.019","article-title":"Genetically engineered mouse models of Parkinson\u2019s disease","volume":"88","author":"Crabtree","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0285","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/brain\/awr039","article-title":"Harnessing neuroplasticity for clinical applications","volume":"134","author":"Cramer","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0290","first-page":"1406","article-title":"Dopaminergic-cholinergic imbalance in movement disorders: a role for the novel striatal dopamine D2- muscarinic acetylcholine M1 receptor heteromer","volume":"16","author":"Crans","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0295","doi-asserted-by":"crossref","first-page":"vii","DOI":"10.1682\/JRRD.2010.02.0017","article-title":"Functional imaging and related techniques: an introduction for rehabilitation researchers","volume":"47","author":"Crosson","year":"2010","journal-title":"J. Rehabil. Res. Dev."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0300","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1038\/s41467-025-59064-y","article-title":"PKA plays a conserved role in regulating gene expression and metabolic adaptation by phosphorylating Rpd3\/HDAC1","volume":"16","author":"Dai","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0305","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bbr.2011.10.002","article-title":"An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 \u0394GAG knock-in mice","volume":"226","author":"Dang","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00330","article-title":"Neuromodulation techniques \u2013 from non-invasive brain stimulation to deep brain stimulation","volume":"21","author":"Davidson","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0315","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40263-015-0278-3","article-title":"Update on the mechanism of action of aripiprazole: translational insights into antipsychotic strategies beyond dopamine receptor antagonism","volume":"29","author":"De Bartolomeis","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106078","article-title":"Present and future antipsychotic drugs: a systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective","volume":"176","author":"de Bartolomeis","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0325","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.3390\/biomedicines10123183","article-title":"Antipsychotics-induced changes in synaptic architecture and functional connectivity: translational implications for treatment response and resistance","volume":"10","author":"de Bartolomeis","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0330","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1208\/s12248-010-9247-4","article-title":"Dopamine D2 occupancy as a biomarker for antipsychotics: quantifying the relationship with efficacy and extrapyramidal symptoms","volume":"13","author":"De Greef","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0335","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10571-024-01529-7","article-title":"AMPA receptors in synaptic plasticity, memory function, and brain diseases","volume":"45","author":"de Le\u00f3n-L\u00f3pez","year":"2025","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0340","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/antiox12040975","article-title":"Schizophrenia synaptic pathology and antipsychotic treatment in the framework of oxidative and mitochondrial dysfunction: translational highlights for the clinics and treatment","volume":"12","author":"De Simone","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0345","first-page":"14","article-title":"Tardive Dyskinesia: spotlight on current approaches to treatment. focus","volume":"19","author":"Debrey","year":"2021","journal-title":"J. Life Long Learn. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0350","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/tra.12295","article-title":"Synaptic cytoskeletal plasticity in the prefrontal cortex following psychostimulant exposure","volume":"16","author":"DePoy","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0355","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.3390\/ijms26167792","article-title":"Reliable new biomarkers of mitochondrial oxidative stress and neuroinflammation in cerebrospinal fluid and plasma from Alzheimer\u2019s disease patients: a pilot study","volume":"26","author":"Di Lorenzo","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0360","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1021\/acschemneuro.2c00810","article-title":"Increased synaptic ATP release and CD73-mediated formation of extracellular adenosine in the control of behavioral and electrophysiological modifications caused by chronic stress","volume":"14","author":"Dias","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0365","first-page":"S959","article-title":"Tardive dyskinesia: apropos of a case. This is a case related to drug side effects, whose uniqueness lies in the time of onset of symptoms, Tardive dyskinesia is a drug-induced hyperkinetic movement disorder","volume":"66","author":"D\u00edaz","year":"2023","journal-title":"Europ. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0370","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/656370","article-title":"Second-generation antipsychotics and extrapyramidal adverse effects","volume":"2014","author":"Divac","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0375","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2217\/14622416.8.11.1597","article-title":"CYP2D6 polymorphism: Implications for antipsychotic drug response, schizophrenia and personality traits","volume":"8","author":"Dorado","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0380","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2015.01.022","article-title":"Spine synapse remodeling in the pathophysiology and treatment of depression","volume":"601","author":"Duman","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0385","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/ijms22010059","article-title":"Glutamatergic dysfunction and synaptic ultrastructural alterations in Schizophrenia and autism spectrum disorder: evidence from human and rodent studies","volume":"22","author":"Eltokhi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0390","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/ilar\/ilx021","article-title":"Nonhuman primate models of neurodegenerative disorders","volume":"58","author":"Emborg","year":"2017","journal-title":"ILAR J."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2026.108170","article-title":"Mitochondrial dysfunction as a driver of chronic pain: new insights and therapeutic prospects","volume":"227","author":"Fan","year":"2026","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0400","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41687-023-00679-4","article-title":"The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation","volume":"8","author":"Farber","year":"2024","journal-title":"J. Patient. Rep. Outcomes"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0405","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnsys.2017.00025","article-title":"Cortico-striatal-thalamic loop circuits of the orbitofrontal cortex: promising therapeutic targets in psychiatric illness","volume":"11","author":"Fettes","year":"2017","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1456052","article-title":"Histone post-translational modification and heterochromatin alterations in neurodegeneration: revealing novel disease pathways and potential therapeutics","volume":"17","author":"Fisher","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0415","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.neuro.31.060407.125631","article-title":"Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system","volume":"31","author":"Flavell","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0420","first-page":"13","article-title":"Efficacy and safety of VMAT-2 inhibitors and dopamine stabilizers for Huntington\u2019s Chorea: a systematic review, meta-analysis, and trial sequential analysis","volume":"13","author":"Floridia Rietmann","year":"2025","journal-title":"Med. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2025.1661342","article-title":"AMPA receptors in the evolving synapse: structure, function, and disease implications","volume":"17","author":"Francis","year":"2025","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0430","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/2045125316672136","article-title":"Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole","volume":"7","author":"Frankel","year":"2016","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0435","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.parkreldis.2018.11.017","article-title":"Tardive dyskinesia: Who gets it and why","volume":"59","author":"Frei","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0440","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/bs.pmbts.2015.03.008","article-title":"Trafficking of \u03b2-adrenergic receptors: implications in intracellular receptor signaling","volume":"132","author":"Fu","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0445","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fnana.2015.00005","article-title":"Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state","volume":"9","author":"Galvan","year":"2015","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0450","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/428010","article-title":"Mechanism of oxidative stress in neurodegeneration","volume":"2012","author":"Gandhi","year":"2012","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0455","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2022.1002960","article-title":"Segregation of D1 and D2 dopamine receptors in the striatal direct and indirect pathways: an historical perspective","volume":"14","author":"Gerfen","year":"2023","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0465","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/npp.2008.116","article-title":"D2-Receptor upregulation is dependent upon temporal course of D2-occupancy: a Longitudinal [11C]-Raclopride PET study in cats","volume":"34","author":"Ginovart","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0470","article-title":"Rapid, transient synaptic plasticity in addiction","volume":"76","author":"Gipson","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0475","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/biomimetics10100640","article-title":"Digital twin cognition: AI-biomarker integration in biomimetic neuropsychology","volume":"10","author":"Gkintoni","year":"2025","journal-title":"Biomimetics"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0480","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuroscience.2012.04.044","article-title":"Dendritic spine pathology in Schizophrenia","volume":"251","author":"Glausier","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0485","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/biomedicines10040870","article-title":"Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor \u03bc1 (rs1799971) polymorphic risk alleles in patients with opioid use disorder: a preponderance of dopaminergic mechanisms?","volume":"10","author":"Gondr\u00e9-Lewis","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1512591","article-title":"Direct effects of prolonged TNF-\u03b1 and IL-6 exposure on neural activity in human iPSC-derived neuron-astrocyte co-cultures","volume":"19","author":"Goshi","year":"2025","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106741","article-title":"Epigenetic and long-term effects of nicotine on biology, behavior, and health","volume":"192","author":"Gould","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0500","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/npp.2009.189","article-title":"Impact of D2 receptor internalization on binding affinity of neuroimaging radiotracers","volume":"35","author":"Guo","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0505","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuroscience.2025.01.021","article-title":"Disruptions in cellular communication: molecular interplay between glutamate\/NMDA signalling and MAPK pathways in neurological disorders","volume":"569","author":"Gupta","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2026.1762930","article-title":"From synapse to system: mechanistic pathways of neural signaling dysfunction in psychiatric disorders","volume":"14","author":"Gupta","year":"2026","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0515","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.3390\/cimb46060345","article-title":"Multi omics applications in biological systems","volume":"46","author":"Gutierrez Reyes","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0520","doi-asserted-by":"crossref","DOI":"10.1002\/cpns.68","article-title":"Haloperidol-induced preclinical Tardive Dyskinesia model in rats","volume":"88","author":"Guzen","year":"2019","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0525","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1021\/acs.chemrestox.1c00327","article-title":"Effects of CYP2D6 genetic polymorphism and drug interaction on the metabolism of dacomitinib","volume":"35","author":"Han","year":"2021","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0530","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1017\/S109285292000200X","article-title":"Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice","volume":"27","author":"Hauser","year":"2020","journal-title":"CNS Spectr."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0535","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jns.2006.05.009","article-title":"Repetitive transcranial magnetic stimulation to improve mood and motor function in Parkinson\u2019s disease","volume":"248","author":"Helmich","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0540","doi-asserted-by":"crossref","first-page":"8987","DOI":"10.1523\/JNEUROSCI.20-24-08987.2000","article-title":"D2 Dopamine receptors in striatal medium spiny neurons reduce L-Type Ca2+ currents and excitability via a Novel PLC\u03b21\u2013IP3\u2013calcineurin-signaling cascade","volume":"20","author":"Hern\u00e1dez-L\u00f3pez","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0545","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/pharmaceutics16020244","article-title":"Clinical utility and implementation of pharmacogenomics for the personalisation of antipsychotic treatments","volume":"16","author":"Hernandez","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0550","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","article-title":"Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode Schizophrenia","volume":"68","author":"Ho","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0555","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.schres.2004.02.017","article-title":"GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum","volume":"72","author":"Hossein Fatemi","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0560","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1083\/jcb.201003008","article-title":"Actin in dendritic spines: connecting dynamics to function","volume":"189","author":"Hotulainen","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0565","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.freeradbiomed.2025.05.426","article-title":"Protective effect of norepinephrine, dopamine and N-methyldopamine against chemically-induced oxidative ferroptosis in HT22 neuronal cells: protein disulfide isomerase as a mechanistic target for protection","volume":"237","author":"Hou","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0570","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fnins.2019.00790","article-title":"Therapeutic potential of neurotrophins for repair after brain injury: a helping hand from biomaterials","volume":"13","author":"Houlton","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0575","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.conb.2012.01.007","article-title":"Synaptic plasticity of NMDA receptors: mechanisms and functional implications","volume":"22","author":"Hunt","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0580","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s44319-024-00056-2","article-title":"Converging synaptic and network dysfunctions in distinct autoimmune encephalitis","volume":"25","author":"Hunter","year":"2024","journal-title":"EMBO Rep."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0585","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/biomedicines11030895","article-title":"Dopamine dynamics and neurobiology of non-response to antipsychotics, relevance for treatment resistant schizophrenia: a systematic review and critical appraisal","volume":"11","author":"Iasevoli","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0590","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1038\/s41467-020-20221-0","article-title":"Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone","volume":"11","author":"Im","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046488","article-title":"Effects of Dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[\u03b2-11C]DOPA","volume":"7","author":"Ito","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107329","article-title":"A precision medicine approach to personalized prescribing using genetic and nongenetic factors for clinical decision-making","volume":"165","author":"Jamrat","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0605","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1038\/s41598-023-29792-6","article-title":"Transcranial direct current stimulation (tDCS) in depression induces structural plasticity","volume":"13","author":"Jog","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0610","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1038\/s41467-025-64379-x","article-title":"A memory transcriptome time course reveals essential long-term memory transcription factors","volume":"16","author":"Jones","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0615","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1017\/S0033291722000423","article-title":"Differential alterations in brain structural network organization during addiction between adolescents and adults","volume":"53","author":"Joo","year":"2023","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0620","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.2174\/1570159X19666210125152815","article-title":"Recent discussions on dopamine supersensitivity psychosis: eight points to consider when diagnosing treatment-resistant Schizophrenia","volume":"19","author":"Kanahara","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0625","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5152\/npa.2015.10122","article-title":"Withdrawal-emergent dyskinesia and supersensitivity psychosis due to olanzapine use","volume":"53","author":"Kara\u015f","year":"2016","journal-title":"Noro Psikiyatr. Ars."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0630","first-page":"289","article-title":"Preclinical progression of neurodegenerative diseases","volume":"80","author":"Katsuno","year":"2018","journal-title":"Nagoya J. Med. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1726144","article-title":"Therapeutic and preventive strategies based on the maladaptive plasticity hypothesis for Alzheimer\u2019s disease","volume":"17","author":"Kawabata","year":"2026","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0640","first-page":"4123","article-title":"Medications for psychosis: Dopamine blockers and dopamine partial agonists (antipsychotics)","author":"Kim","year":"2024","journal-title":"Tasman\u2019s psychiatry, Fifth Edition"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0645","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.785592","article-title":"Potential mechanisms for why not all antipsychotics are able to occupy Dopamine D3 receptors in the brain in vivo","volume":"13","author":"Kiss","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0650","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00002826-198406000-00006","article-title":"The reversibility of \u201cpermanent\u201d tardive dyskinesia","volume":"7","author":"Klawans","year":"1984","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0655","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","article-title":"Dopamine: functions, signaling, and association with neurological diseases","volume":"39","author":"Klein","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0660","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.3390\/ijms20133207","article-title":"Potential utility of biased GPCR signaling for treatment of psychiatric disorders","volume":"20","author":"Komatsu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0665","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1124\/jpet.118.247981","article-title":"Dopamine D2 receptor supersensitivity as a spectrum of neurotoxicity and status in psychiatric disorders","volume":"366","author":"Kostrzewa","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0670","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.parkreldis.2016.06.005","article-title":"Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson\u2019s disease patients","volume":"30","author":"Krishnamoorthy","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0675","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1358\/dot.2003.39.1.799430","article-title":"Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives","volume":"39","author":"Kulkari","year":"2003","journal-title":"Drugs Today (Barc)."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0680","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2217\/pgs.16.26","article-title":"Pharmacogenetics of tardive dyskinesia: an updated review of the literature","volume":"17","author":"Lanning","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0685","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pharmthera.2004.10.012","article-title":"Modulation of neurotransmitter release by the second messenger-activated protein kinases: implications for presynaptic plasticity","volume":"105","author":"Leenders","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2024.105255","article-title":"A Longitudinal treatment effect analysis of antipsychotics on behavior of residents in long-term care","volume":"25","author":"Leme","year":"2024","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0695","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/jnc.13713","article-title":"Synaptopathies: synaptic dysfunction in neurological disorders \u2013 a review from students to students","volume":"138","author":"Lepeta","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0700","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jdbs.2026.02.001","article-title":"Neurophysiology in deep brain stimulation: Bridging clinical practice and systems neuroscience","volume":"12","author":"Lewentz","year":"2026","journal-title":"Deep Brain Stimul."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0705","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.87644","article-title":"Multiple dynamic interactions from basal ganglia direct and indirect pathways mediate action selection","volume":"12","author":"Li","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0710","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1471-4159.2004.02569.x","article-title":"Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling","volume":"90","author":"Li","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynpai.2019.100028","article-title":"Cyclic nucleotide signaling in sensory neuron hyperexcitability and chronic pain after nerve injury","volume":"6","author":"Li","year":"2019","journal-title":"Neurobiol. Pain"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0720","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2025.1621017","article-title":"Combined inhibition of dopamine D1\/D2 receptors induces cognitive and emotional dysfunction through oxidative stress and dopaminergic neuron damage","volume":"19","author":"Li","year":"2025","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0725","article-title":"AI-enabled wearables for motor function assessment and rehabilitation in Parkinson disease: scoping review","volume":"28","author":"Li","year":"2026","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0730","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/psychiatryint6040134","article-title":"Exploring biological risk factors in treatment-resistant depression","volume":"6","author":"Lievanos-Ruiz","year":"2025","journal-title":"Psychiatry Int."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0735","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/jcph.6152","article-title":"Exposure-efficacy analysis and Dopamine D2 receptor occupancy in adults with schizophrenia after treatment with the monthly intramuscular injectable risperidone ISM","volume":"65","author":"Lindauer","year":"2024","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0740","doi-asserted-by":"crossref","DOI":"10.1017\/S0033291725101591","article-title":"Successful antipsychotic dose tapering leading to better cognition in patients with remitted psychosis: results of guided antipsychotic reduction to reach minimum effective dose (GARMED) trial","volume":"55","author":"Liu","year":"2025","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0745","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41582-018-0128-2","article-title":"Deep brain stimulation: current challenges and future directions","volume":"15","author":"Lozano","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0750","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ajpath.2015.09.023","article-title":"Dopaminergic neurons and brain reward pathways: from neurogenesis to circuit assembly","volume":"186","author":"Luo","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0755","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005710","article-title":"NMDA receptor-dependent long-term potentiation and long-term depression (LTP\/LTD)","volume":"4","author":"L\u00fcscher","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0760","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2025.1722453","article-title":"Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook","volume":"16","author":"Lv","year":"2026","journal-title":"Front. Genet."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0765","first-page":"61","article-title":"Genetics of common antipsychotic-induced adverse effects","volume":"2","author":"MacNeil","year":"2016","journal-title":"Mol. Neuropsychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0770","doi-asserted-by":"crossref","first-page":"7520","DOI":"10.3390\/ijms26157520","article-title":"Antioxidants and reactive oxygen species: shaping human health and disease outcomes","volume":"26","author":"Manful","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0775","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/ijms25010574","article-title":"Mitochondrial dysfunction and Coenzyme Q10 supplementation in post-viral fatigue syndrome: an overview","volume":"25","author":"Mantle","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0780","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/S0893-133X(99)00105-0","article-title":"Limitations of Dopamine-D2 antagonists and the search for novel antipsychotic strategies","volume":"21","author":"Marder","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0785","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2174\/011570159X336597241217062042","article-title":"Synaptic Interactions between serotonergic and dopaminergic systems in Parkinson\u2019s Disease","volume":"23","author":"Marino","year":"2025","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0790","series-title":"Neuroscience in the 21st Century 3087\u20133113","article-title":"Cognitive functions as revealed by imaging of the human brain","author":"Martin","year":"2022"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0795","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.0803522105","article-title":"Antagonism of dopamine D2 receptor\/\u03b2-arrestin 2 interaction is a common property of clinically effective antipsychotics","volume":"105","author":"Masri","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0800","first-page":"36","article-title":"Antipsychotic-induced movement disorders: evaluation and treatment","volume":"2","author":"Mathews","year":"2005","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0805","article-title":"From assessment to intervention: evidence-based approaches in tardive dyskinesia","volume":"30","author":"Matthews","year":"2025","journal-title":"CNS Spectr."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0810","first-page":"1163","article-title":"Clinical pharmacology of atypical antipsychotics: an update","volume":"13","author":"Mauri","year":"2014","journal-title":"EXCLI J."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0815","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbadis.2011.10.006","article-title":"Antioxidant clinical trials in mild cognitive impairment and Alzheimer\u2019s disease","volume":"1822","author":"Mecocci","year":"2012","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0820","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.3390\/ijms27073076","article-title":"N-acetylcysteine in neurological disorders: a systematic review of clinical and translational evidence across seven disorders","volume":"27","author":"M\u00eendreanu","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0825","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/0269881116654776","article-title":"Neural changes induced by antipsychotic administration in adolescence: a review of studies in laboratory rodents","volume":"30","author":"Moe","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0830","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1021\/acsabm.0c01319","article-title":"Dendrimer architectonics to treat cancer and neurodegenerative diseases with implications in theranostics and personalized medicine","volume":"4","author":"Moorthy","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0835","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbadis.2009.10.007","article-title":"Mitochondria: a Therapeutic Target in Neurodegeneration","volume":"1802","author":"Moreira","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0840","series-title":"Third-Generation Antipsychotics: The Quest for the Key to Neurotrophism","first-page":"391","volume":"15","author":"Mucci","year":"2025"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0845","article-title":"Atypical antipsychotic-induced Tardive Dyskinesia in a Middle-Aged Schizophrenic Patient: a case report","volume":"16","author":"Mulla","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0850","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/ijms26052231","article-title":"Molecular biomarkers in neurological diseases: advances in diagnosis and prognosis","volume":"26","author":"Myrou","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0855","doi-asserted-by":"crossref","first-page":"79","DOI":"10.18433\/J3MK59","article-title":"Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice","volume":"12","author":"Naik","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0860","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/YIC.0000000000000347","article-title":"Longitudinal changes in antipsychotic dose in patients treated with long-acting injectable second-generation antipsychotics","volume":"36","author":"Nakajima","year":"2021","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0865","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/NDT.S494458","article-title":"The prevalence of tardive dyskinesia in patients with Schizophrenia treated with antipsychotics in Malaysia","volume":"21","author":"Nedunjelian","year":"2025","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0870","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0006-8993(98)01191-3","article-title":"DeltaFosB: a molecular mediator of long-term neural and behavioral plasticity","volume":"835","author":"Nestler","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0875","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pneurobio.2003.12.003","article-title":"Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases","volume":"71","author":"Nguyen","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0880","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.3390\/ijms25126521","article-title":"Glutamate-mediated excitotoxicity in the pathogenesis and treatment of neurodevelopmental and adult mental disorders","volume":"25","author":"Nicosia","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0885","doi-asserted-by":"crossref","first-page":"30144","DOI":"10.3390\/ijms161226228","article-title":"Alterations of Dopamine D2 receptors and related receptor-interacting proteins in schizophrenia: the pivotal position of Dopamine supersensitivity psychosis in treatment-resistant Schizophrenia","volume":"16","author":"Oda","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0890","doi-asserted-by":"crossref","first-page":"30144","DOI":"10.3390\/ijms161226228","article-title":"Alterations of Dopamine D2 receptors and related receptor-interacting proteins in schizophrenia: the pivotal position of Dopamine supersensitivity psychosis in treatment-resistant Schizophrenia","volume":"16","author":"Oda","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0895","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.3390\/ijms26104929","article-title":"Reversing epigenetic dysregulation in neurodegenerative diseases: mechanistic and therapeutic considerations","volume":"26","author":"Olawade","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0900","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-022-01078-9","article-title":"The role of histone modifications: from neurodevelopment to neurodiseases","volume":"7","author":"Park","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0905","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3390\/ijms23031219","article-title":"Adenosine receptors in neuropsychiatric disorders: fine regulators of neurotransmission and potential therapeutic targets","volume":"23","author":"Pasquini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0910","doi-asserted-by":"crossref","DOI":"10.1017\/S1092852925100643","article-title":"VMAT2 inhibitors for the treatment of tardive dyskinesia: a narrative review","volume":"30","author":"Patel","year":"2025","journal-title":"CNS Spectr."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0915","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-019-1385-4","article-title":"Risk assessment and prediction of TD incidence in psychiatric patients taking concomitant antipsychotics: a retrospective data analysis","volume":"19","author":"Patterson-Lomba","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0920","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3389\/fneur.2019.01016","article-title":"The rodent models of dyskinesia and their behavioral assessment","volume":"10","author":"Peng","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0925","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2147\/NDT.S455279","article-title":"New therapeutic targets and drugs for schizophrenia beyond Dopamine D2 receptor antagonists","volume":"20","author":"Peng","year":"2024","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0930","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00702-018-1845-9","article-title":"The striatal cholinergic system in L-dopa-induced dyskinesias","volume":"125","author":"Perez","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0935","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41531-025-01133-6","article-title":"Cerebral perfusion imaging predicts levodopa-induced dyskinesia in Parkinsonian rat model","volume":"11","author":"Perron","year":"2025","journal-title":"npj Parkinson\u2019s Disease"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0940","doi-asserted-by":"crossref","first-page":"15446","DOI":"10.3389\/dyst.2025.15446","article-title":"Brain network pathophysiology in dystonia","volume":"4","author":"Peterson","year":"2026","journal-title":"Dystonia"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0945","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/antiox9080647","article-title":"Mitochondrial dysfunction, oxidative stress, and neuroinflammation: intertwined roads to neurodegeneration","volume":"9","author":"Picca","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0950","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2202-14-123","article-title":"Structural brain abnormalities in cervical dystonia","volume":"14","author":"Prell","year":"2013","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0955","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pnpbp.2014.05.001","article-title":"Effects of antipsychotic D2 antagonists on long-term potentiation in animals and implications for human studies","volume":"0","author":"Price","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0960","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.molmed.2011.03.003","article-title":"The contribution of GABAergic dysfunction to neurodevelopmental disorders","volume":"17","author":"Ramamoorthi","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0965","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","article-title":"Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: a review of the literature","volume":"10","author":"Ramesh","year":"2023","journal-title":"AIMS Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0970","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbi.2015.08.011","article-title":"GABAergic modulation with classical benzodiazepines prevent stress-induced neuro-immune dysregulation and behavioral alterations","volume":"51","author":"Ramirez","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0975","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3389\/fpsyt.2018.00702","article-title":"Antipsychotic drug responsiveness and dopamine receptor signaling; old players and new prospects","volume":"9","author":"Rampino","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0980","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bmcl.2015.12.024","article-title":"Biased agonism: an emerging paradigm in GPCR drug discovery","volume":"26","author":"Rankovic","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pnpbp.2026.111846_bb0985","series-title":"Tardive Dyskinesia","author":"Raza","year":"2026"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0990","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1016\/j.apsb.2025.07.030","article-title":"Artificial intelligence-driven multi-omics approaches in Alzheimer\u2019s disease: progress, challenges, and future directions","volume":"15","author":"Ren","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.pnpbp.2026.111846_bb0995","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1021\/acschemneuro.1c00723","article-title":"\u0394FOSB: a potentially druggable master orchestrator of activity-dependent gene expression","volume":"13","author":"Robison","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1000","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/antiox14020220","article-title":"Multi-target profiling of antioxidant compounds, including repurposing and combination strategies","volume":"14","author":"Rocca","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/molpharm.122.000606","article-title":"Gait abnormalities and Aberrant D2 receptor expression and signaling in mice carrying the human pathogenic mutation DRD2I212F","volume":"103","author":"Rodriguez-Contreras","year":"2023","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1010","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(25)01072-4","article-title":"Vesicular monoamine transport inhibitors: current uses and future directions","volume":"406","author":"Rosenthal","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1015","doi-asserted-by":"crossref","DOI":"10.1002\/npr2.70049","article-title":"Reporting frequency of antipsychotics-induced Tardive Dyskinesia and other extrapyramidal symptoms: analysis based on a spontaneous reporting system database in Japan","volume":"45","author":"Saga","year":"2025","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2025.121635","article-title":"Neurochemical changes in GABA+, Glx, and the excitatory\/inhibitory ratio in the calcarine cortex with healthy aging","volume":"324","author":"Salsano","year":"2025","journal-title":"Neuroimage"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1025","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41398-023-02609-w","article-title":"Chronic treatment with D2-antagonist haloperidol leads to inhibitory\/excitatory imbalance in striatal D1-neurons","volume":"13","author":"Santa","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1030","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1523\/JNEUROSCI.0622-17.2017","article-title":"Selective vulnerability of Striatal D2 versus D1 Dopamine receptor-expressing medium spiny neurons in HIV-1 Tat transgenic male mice","volume":"37","author":"Schier","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2009.01.001","article-title":"Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia","volume":"34","author":"Sciamanna","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0330277","article-title":"Long-term neurological consequences following benzodiazepine exposure: a scoping review","volume":"20","author":"Shade","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1045","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3390\/biomedicines11051313","article-title":"The effects of antipsychotics in experimental models of Krabbe Disease","volume":"11","author":"Sharma","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1050","first-page":"2191","article-title":"Antioxidants as potential therapeutics in neurodegeneration","author":"Sharma","year":"2012","journal-title":"Syst. Biol. Free Radicals Antioxid."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1055","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/s41380-025-03013-0","article-title":"Erasing \u201cbad memories\u201d: reversing aberrant synaptic plasticity as therapy for neurological and psychiatric disorders","volume":"30","author":"Shi","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1060","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1038\/s41380-023-02203-y","article-title":"Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis","volume":"28","author":"Siafis","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/mps3040066","article-title":"Detecting oxidative stress biomarkers in neurodegenerative disease models and patients","volume":"3","author":"Sidorova","year":"2020","journal-title":"Methods Protocols"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1070","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41380-021-01253-4","article-title":"How changes in dopamine D2 receptor levels alter striatal circuit function and motivation","volume":"27","author":"Simpson","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1075","article-title":"Delayed presentation of antipsychotic withdrawal tardive dyskinesia: a case report","volume":"15","author":"Solanki","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1080","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2147\/TCRM.S117321","article-title":"Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review","volume":"13","author":"Solmi","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1085","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2147\/DDDT.S133205","article-title":"Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Solmi","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1090","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41380-024-02733-z","article-title":"Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysis","volume":"30","author":"Solmi","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1095","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41398-025-03582-2","article-title":"The sense and nonsense of antipsychotic combinations: a model for dopamine D2\/3 receptor occupancy","volume":"15","author":"Spangemacher","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/cells10040735","article-title":"Dopamine: the neuromodulator of long-term synaptic plasticity, reward and movement control","volume":"10","author":"Speranza","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1105","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1025414","article-title":"Crossroad between current knowledge and new perspective of diagnostic and therapy of late-onset schizophrenia and very late-onset schizophrenia-like psychosis: an update","volume":"13","author":"St\u0229pie\u0144-Wyrobiec","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/17460441.2020.1816962","article-title":"Multi-targeted drug design strategies for the treatment of schizophrenia","volume":"16","author":"St\u0119pnicki","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1115","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.2174\/1381612821666150605111236","article-title":"Atypical antipsychotics and inverse agonism at 5-HT2 receptors","volume":"21","author":"Sullivan","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1120","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.3390\/ijerph19094942","article-title":"Impact of the DRD2 polymorphisms on the effectiveness of the training program","volume":"19","author":"\u015awita\u0142a","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/FBP.0000000000000563","article-title":"The role of glutamate receptors and their interactions with dopamine and other neurotransmitters in the development of tardive dyskinesia: preclinical and clinical results","volume":"31","author":"Szota","year":"2020","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1130","article-title":"Dopamine supersensitivity psychosis resolved with electroconvulsive therapy (ECT) in a patient with treatment-resistant schizophrenia: a case report","volume":"17","author":"Takano","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1135","doi-asserted-by":"crossref","DOI":"10.1177\/20451253221117313","article-title":"Pathophysiology, prognosis and treatment of tardive dyskinesia","volume":"12","author":"Takeuchi","year":"2022","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1140","doi-asserted-by":"crossref","first-page":"9841","DOI":"10.1021\/acs.jmedchem.8b00435","article-title":"Biased ligands of G protein-coupled receptors (GPCRs): structure\u2013functional selectivity relationships (SFSRs) and therapeutic potential","volume":"61","author":"Tan","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.schres.2012.10.015","article-title":"Interventions to reduce antipsychotic polypharmacy: a systematic review","volume":"143","author":"Tani","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1150","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2025.1727707","article-title":"Merging multimodal digital biomarkers into \u201cDigital Neuro Fingerprints\u201d for precision neurology in dementias: the promise of the right treatment for the right patient at the right time in the age of AI","volume":"7","author":"Tarnanas","year":"2026","journal-title":"Front. Digital Health"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1155","doi-asserted-by":"crossref","DOI":"10.1177\/20451253221144347","article-title":"Tardive dyskinesia: understanding current challenges in diagnosis and treatment","volume":"13","author":"Taylor","year":"2023","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.brs.2026.103120","article-title":"Accelerating the therapeutic effects of non-invasive brain stimulation: a Neuroscience School of Advanced Studies (NSAS) challenge workshop","volume":"19","author":"Taylor","year":"2026","journal-title":"Brain Stimul."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2024.115341","article-title":"Atypical antipsychotics improve dendritic spine pathology in temporal lobe cortex neurons in a developmental rodent model of schizophrenia","volume":"478","author":"Tendilla-Beltr\u00e1n","year":"2025","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1170","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/mds.25107","article-title":"Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis","volume":"27","author":"Teo","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1175","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101628","article-title":"Pathophysiology of neurodegenerative diseases: an interplay among axonal transport failure, oxidative stress, and inflammation?","volume":"59","author":"Tesco","year":"2022","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/ijms16010193","article-title":"Oxidative stress and its significant roles in neurodegenerative diseases and cancer","volume":"16","author":"Thanan","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1185","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nbd.2014.08.006","article-title":"Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models","volume":"71","author":"Thiele","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108795","article-title":"Cannabinoid receptor 1 ligands: biased signaling mechanisms driving functionally selective drug discovery","volume":"267","author":"Tian","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1195","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1176\/appi.ajp.20240321","article-title":"Continuous dopamine D2 receptor blockade and long-term outcome in first-episode schizophrenia","volume":"182","author":"Tiihonen","year":"2025","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1200","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.3390\/ijms26094271","article-title":"From synaptic plasticity to neurodegeneration: BDNF as a transformative target in medicine","volume":"26","author":"Toader","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1205","first-page":"13","article-title":"Valbenazine and Deutetrabenazine for Tardive Dyskinesia","volume":"15","author":"Touma","year":"2018","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1210","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/brain\/awab242","article-title":"Dopamine-dependent early synaptic and motor dysfunctions induced by \u03b1-synuclein in the nigrostriatal circuit","volume":"144","author":"Tozzi","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1215","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103380","article-title":"Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activity: a systematic review and meta-analysis","volume":"77","author":"Traten\u0161ek","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1220","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2012.09.023","article-title":"Dopaminergic modulation of synaptic transmission in cortex and striatum","volume":"76","author":"Tritsch","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1225","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.834129","article-title":"Genetic factors associated With Tardive Dyskinesia: from pre-clinical models to clinical studies","volume":"12","author":"Tsermpini","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1230","doi-asserted-by":"crossref","first-page":"12366","DOI":"10.3390\/ijms252212366","article-title":"NMDA receptors in neurodevelopmental disorders: pathophysiology and disease models","volume":"25","author":"Tumdam","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1235","doi-asserted-by":"crossref","first-page":"9303","DOI":"10.3390\/ijms24119303","article-title":"Expected and unexpected effects of pharmacological antioxidants","volume":"24","author":"Tyuryaeva","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1240","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1523\/JNEUROSCI.4970-05.2006","article-title":"Regulation of \u0394FosB stability by phosphorylation","volume":"26","author":"Ulery","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1245","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110753","article-title":"The direct and indirect pathways of the basal ganglia antagonistically influence cortical activity and perceptual decisions","volume":"27","author":"van Beest","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1250","doi-asserted-by":"crossref","first-page":"36","DOI":"10.64719\/pb.4612","article-title":"Assesment of risk factors for Tardive Dyskinesia","volume":"50","author":"Vardar","year":"2020","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1255","series-title":"Tremor and Other Hyperkinetic Movements","first-page":"282","article-title":"Reversibility of Tardive Dyskinesia syndrome","volume":"4","author":"Vinuela","year":"2014"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1260","article-title":"An update on Tardive Dyskinesia: from phenomenology to treatment","volume":"3","author":"Waln","year":"2013","journal-title":"Tremor Other Hyperkinetic Movem."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1265","article-title":"Deutetrabenazine and modified electroconvulsive therapy for Tardive Dyskinesia with recurrent depression: a case report","volume":"18","author":"Wan","year":"2026","journal-title":"Cureus"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1270","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s40120-018-0105-0","article-title":"Antipsychotic-related movement disorders: drug-induced Parkinsonism vs. Tardive Dyskinesia\u2014key differences in pathophysiology and clinical management","volume":"7","author":"Ward","year":"2018","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1275","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1152\/jn.00161.2013","article-title":"Supersensitive presynaptic dopamine D2 receptor inhibition of the striatopallidal projection in nigrostriatal dopamine-deficient mice","volume":"110","author":"Wei","year":"2013","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1280","series-title":"Functional Magnetic Resonance Imaging (fMRI): An Invaluable Tool in Translational Neuroscience","author":"Whitten","year":"2012"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1285","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/mds.23695","article-title":"Milestones in research on the pathophysiology of Parkinson\u2019s Disease","volume":"26","author":"Wichmann","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1290","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.aca.2020.10.038","article-title":"Multi-omics integration in biomedical research \u2013 a metabolomics-centric review","volume":"1141","author":"W\u00f6rheide","year":"2020","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/NDT.S595872","article-title":"Resting-state EEG characteristics of tardive dyskinesia: spectral and network connectivity insights","volume":"22","author":"Yan","year":"2026","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1300","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1700692","article-title":"Microglia-orchestrated neuroinflammation and synaptic remodeling: roles of pro-inflammatory cytokines and receptors in neurodegeneration","volume":"19","author":"Yang","year":"2025","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1305","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s10194-025-02229-3","article-title":"Downregulation of neuronal DRD2 drives microglia synaptic pruning and results in cognitive deficits by promoting CCL2 release in a rat model of chronic migraine","volume":"27","author":"Yang","year":"2026","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1310","article-title":"Acute exacerbation of major depressive disorder following valbenazine treatment for tardive dyskinesia: a case report","volume":"4","author":"Yano","year":"2025","journal-title":"PCN Rep. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1315","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.neuropharm.2008.07.046","article-title":"Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity","volume":"55","author":"Yashiro","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1320","first-page":"1472","article-title":"Exploring the frontiers of neuroimaging: a review of recent advances in understanding brain functioning and disorders","volume":"13","author":"Yen","year":"2023"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1325","doi-asserted-by":"crossref","DOI":"10.1002\/qub2.70002","article-title":"Revolutionizing multi-omics analysis with artificial intelligence and data processing","volume":"13","author":"Yetgin","year":"2025","journal-title":"Quant. Biol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1330","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2174\/1570159X14666160606093602","article-title":"Antipsychotic induced dopamine supersensitivity psychosis: a comprehensive review","volume":"15","author":"Yin","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1335","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/cells14080571","article-title":"Natural products in the treatment of neuroinflammation at microglia: recent trend and features","volume":"14","author":"Yoon","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1340","series-title":"Neuroanatomy, Basal Ganglia","author":"Young","year":"2023"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1345","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fphar.2015.00225","article-title":"The role of serotonin 5-HT2A receptors in memory and cognition","volume":"6","author":"Zhang","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1350","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1017\/S1461145712001277","article-title":"Efficacy and safety of individual second-generation vs first-generation antipsychotics in first episode psychosis: a systematic review and meta-analysis","volume":"16","author":"Zhang","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1355","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/acschemneuro.3c00608","article-title":"Inhibition of GluN2D-containing NMDA receptors protects dopaminergic neurons against 6-OHDA-induced neurotoxicity via activating ERK\/NRF2\/HO-1 signaling","volume":"15","author":"Zhang","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1360","article-title":"NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies","volume":"17","author":"Zhang","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1365","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2026.111887","article-title":"The dual role of microglia in neurodegenerative diseases: a review","volume":"239","author":"Zhang","year":"2026","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pnpbp.2026.111846_bb1370","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.cell.2026.01.035","article-title":"Genetically encoded fluorescent reporters to visualize \u03b1-synuclein pathology in live brain","volume":"189","author":"Zhang","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1375","article-title":"Applications and challenges of biomarker-based predictive models in proactive health management","volume":"13","author":"Zhao","year":"2025","journal-title":"Front. Public Health"},{"key":"10.1016\/j.pnpbp.2026.111846_bb1380","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5334\/tohm.199","article-title":"Tardive syndromes are rarely reversible after discontinuing dopamine receptor blocking agents: experience from a university-based movement disorder clinic","volume":"4","author":"Zutshi","year":"2014","journal-title":"Tremor Other Hyperkinetic Movem."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626002447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626002447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:16:00Z","timestamp":1785132960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626002447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":276,"alternative-id":["S0278584626002447"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111846","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silent action of dopamine receptor antagonist in synaptic remodelling: Molecular basis of tardive dyskinesia due to chronic antipsychotic exposure","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111846"}}